109 related articles for article (PubMed ID: 8322031)
1. Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers.
Aabakken L; Axelsson CK; Szecsi PB
Scand J Gastroenterol; 1993 Jun; 28(6):557-60. PubMed ID: 8322031
[TBL] [Abstract][Full Text] [Related]
2. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens.
Santucci L; Fiorucci S; Patoia L; Di Matteo FM; Brunori PM; Morelli A
Dig Dis Sci; 1995 Sep; 40(9):2074-80. PubMed ID: 7555467
[TBL] [Abstract][Full Text] [Related]
3. Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers.
Aabakken L; Dybdahl JH; Eidsaunet W; Haaland A; Larsen S; Osnes M
Scand J Gastroenterol; 1989 Oct; 24(8):1007-13. PubMed ID: 2688064
[TBL] [Abstract][Full Text] [Related]
4. Gastroduodenal lesions associated with two different piroxicam formulations. An endoscopic comparison.
Aabakken L; Olaussen B; Mowinckel P; Osnes M
Scand J Gastroenterol; 1992 Dec; 27(12):1049-54. PubMed ID: 1475622
[TBL] [Abstract][Full Text] [Related]
5. [Comparative endoscopic study of gastroduodenal tolerance of piroxicam-beta-cyclodextrin vs piroxicam].
Müller P; Simon B
Z Rheumatol; 1997; 56(2):76-9. PubMed ID: 9235813
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
7. Does sucralfate prevent short-term NSAID induced damage to the gastroduodenal mucosa?
Gudjónsson H; Oddsson E; Thjodleifsson B
Digestion; 1994; 55(6):395-8. PubMed ID: 7705552
[TBL] [Abstract][Full Text] [Related]
8. [Changes in the serum pepsinogen level during therapy with acemtacin retard as a measure of gastroduodenal tolerance].
Kullich W; Klein G
Wien Med Wochenschr; 1991; 141(15):331-5. PubMed ID: 1949833
[TBL] [Abstract][Full Text] [Related]
9. Pepsinogens: physiology, pharmacology pathophysiology and exercise.
Gritti I; Banfi G; Roi GS
Pharmacol Res; 2000 Mar; 41(3):265-81. PubMed ID: 10675278
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen.
Shah AA; Thjodleifsson B; Murray FE; Kay E; Barry M; Sigthorsson G; Gudjonsson H; Oddsson E; Price AB; Fitzgerald DJ; Bjarnason I
Gut; 2001 Mar; 48(3):339-46. PubMed ID: 11171823
[TBL] [Abstract][Full Text] [Related]
11. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
Lazzaroni M; Anderloni A; Bianchi Porro G
Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):833-9. PubMed ID: 11474314
[TBL] [Abstract][Full Text] [Related]
12. [Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases].
Kullich W; Fromme K; Klein G
Wien Med Wochenschr; 1996; 146(17):459-64. PubMed ID: 9045528
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal tolerability of lornoxicam compared to that of naproxen in healthy male volunteers.
Aabakken L; Osnes M; Frenzel W
Aliment Pharmacol Ther; 1996 Apr; 10(2):151-6. PubMed ID: 8730243
[TBL] [Abstract][Full Text] [Related]
14. [Gastroduodenal tolerance of tenoxicam versus diclofenac-Na: an endoscopy double-blind controlled study in healthy probands].
Müller P; Dammann HG; Marinis E; Simon B
Z Rheumatol; 1989; 48(5):243-5. PubMed ID: 2692344
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
Lipscomb GR; Wallis N; Armstrong G; Rees WD
Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs.
Ruina M; Caselli M; Sartori S; Trevisani L; La Corte R; Trotta F; Alvisi V
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574
[TBL] [Abstract][Full Text] [Related]
17. [Value of pepsinogen I in serum as a screening method for early detection of gastroduodenal lesions and follow-up in therapy with non-steroidal antirheumatic drugs].
Kullich W; Pöllmann G; Zmerekar C; Klein G
Z Rheumatol; 1991; 50(1):39-45. PubMed ID: 2058321
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.
Laine L; Sloane R; Ferretti M; Cominelli F
Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
20. Serum level of pepsinogen significantly associated with gastric distress induced by amino-bisphosphonates.
Shiraki M; Yamazaki Y; Kuroda T; Tanaka S; Miyata K
Osteoporos Int; 2011 Jun; 22(6):1717-23. PubMed ID: 21069296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
